Essential Thrombocythemia Market - Top Companies and Manufacturers

Companies Dominating the Essential Thrombocythemia Landscape

Active Biotech AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Incyte
Bayer AG
USV Private Limited.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
AstraZeneca
Takeda Pharmaceutical Company Limited

Browse Key Market Insights with Data Illustration:

Essential Thrombocythemia Market Size Forecasts 2024-2036

In the News

Active Biotech AB announced the approval for tasquinimod Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of myelofibrosis. It creates an important regulatory channel and gives us the opportunity to rapidly progress tasquinimod development in this patient population.
Incyte has announced to receive data from two Limber trials assessing single-agent therapy and combination treatments in patients with myelofibrosis (MF) using ruxolitinib with parsaclisib.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of essential thrombocythemia is evaluated at USD 904 Million.

The essential thrombocythemia market size was over USD 871.05 Million in 2023 and is expected to exceed USD 1.79 Billion by the end of 2036, witnessing over 5.7% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of essential thrombocythemia, and rising investment in research development of new drugs are the major factors driving the market growth.

North America industry share is projected to reach 35% by 2036, driven by rising count of people living with ET in the region.

Active Biotech AB, Incyte, Bayer AG, USV Private Limited., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, AstraZeneca, Takeda Pharmaceutical Company Limited

Essential Thrombocythemia Market - Top Companies and Manufacturers

Companies Dominating the Essential Thrombocythemia Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the essential thrombocythemia market?

What are the factors driving the essential thrombocythemia landscape?

Which region held the largest essential thrombocythemia industry share?

Who are the key players in the essential thrombocythemia sector?